159 related articles for article (PubMed ID: 32476902)
1. Repository corticotropin injection (H.P. Acthar gel) for the treatment of sarcoidosis-induced hypercalciuria and vitamin D dysregulation: a pilot, open label study.
Judson MA; Modi A; Ilyas F; Yucel R
Sarcoidosis Vasc Diffuse Lung Dis; 2018; 35(3):192-197. PubMed ID: 32476902
[No Abstract] [Full Text] [Related]
2. Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.
Mirsaeidi M; Baughman RP; Sahoo D; Tarau E
Pulm Ther; 2023 Jun; 9(2):237-253. PubMed ID: 37072607
[TBL] [Abstract][Full Text] [Related]
3. Repository corticotropin for Chronic Pulmonary Sarcoidosis.
Baughman RP; Sweiss N; Keijsers R; Birring SS; Shipley R; Saketkoo LA; Lower EE
Lung; 2017 Jun; 195(3):313-322. PubMed ID: 28353116
[TBL] [Abstract][Full Text] [Related]
4. Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis.
Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio MP; Wan GJ
J Health Econ Outcomes Res; 2022; 9(1):90-100. PubMed ID: 35529249
[No Abstract] [Full Text] [Related]
5. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records.
Chopra I; Qin Y; Kranyak J; Gallagher JR; Heap K; Carroll S; Wan GJ
Ther Adv Respir Dis; 2019; 13():1753466619888127. PubMed ID: 31722624
[TBL] [Abstract][Full Text] [Related]
6. Repository Corticotropin Injection (Acthar
Wirta D; McLaurin E; Ousler G; Liu J; Kacmaz RO; Grieco J
Ophthalmol Ther; 2021 Dec; 10(4):1077-1092. PubMed ID: 34669183
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis.
Hayes K; Niewoehner J; Rice JB; Downes N; Hagopian E; Ma I; Wan GJ
Adv Ther; 2023 Nov; 40(11):4999-5015. PubMed ID: 37728695
[TBL] [Abstract][Full Text] [Related]
8. Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.
Mirsaeidi M; Baughman RP
Pulm Ther; 2022 Mar; 8(1):43-55. PubMed ID: 35113366
[TBL] [Abstract][Full Text] [Related]
9. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
[TBL] [Abstract][Full Text] [Related]
10. Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis.
Antoniucci DM; Sellmeyer DE; Bilezikian JP; Palermo L; Ensrud KE; Greenspan SL; Black DM
J Clin Endocrinol Metab; 2007 Mar; 92(3):942-7. PubMed ID: 17164314
[TBL] [Abstract][Full Text] [Related]
11. Vitamin-D status and mineral metabolism in two ethnic populations with sarcoidosis.
Capolongo G; Xu LH; Accardo M; Sanduzzi A; Stanziola AA; Colao A; Agostini C; Zacchia M; Capasso G; Adams-Huet B; Moe OW; Maalouf NM; Sakhaee K; Hsia CC
J Investig Med; 2016 Jun; 64(5):1025-34. PubMed ID: 27053725
[TBL] [Abstract][Full Text] [Related]
12. Results from a Prospective, Open-Label, Phase 4 Pilot Study of Repository Corticotropin Injection for Moderate and Severe Dry Eye Disease.
Toyos M; Toyos R; Jodoin B; Bunch R
Ophthalmol Ther; 2022 Jun; 11(3):1231-1240. PubMed ID: 35460497
[TBL] [Abstract][Full Text] [Related]
13. The effect of recombinant PTH(1-34) and PTH(1-84) on serum ionized calcium, 1,25-dihydroxyvitamin D, and urinary calcium excretion: a pilot study.
Piemonte S; Romagnoli E; Cipriani C; Fassino V; Del Fiacco R; Carnevale V; Scillitani A; D'Erasmo E; Tancredi A; Minisola S
Calcif Tissue Int; 2009 Oct; 85(4):287-92. PubMed ID: 19756348
[TBL] [Abstract][Full Text] [Related]
14. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
Ketha H; Wadams H; Lteif A; Singh RJ
J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. A case of renal sarcoidosis: a special reference to calcium metabolism as a diagnostic and the therapeutic implications.
Mitome J; Kawaguchi Y; Arase S; Horino T; Okada H; Osaka N; Hanaoka K; Shimada T; Kawamura T; Hosoya T; Yamaguchi Y; Hano H
Clin Exp Nephrol; 2004 Dec; 8(4):375-9. PubMed ID: 15619040
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications.
Philbin M; Niewoehner J; Wan GJ
Adv Ther; 2017 Aug; 34(8):1775-1790. PubMed ID: 28660550
[TBL] [Abstract][Full Text] [Related]
18. Resorptive versus absorptive hypercalciuria in sarcoidosis: correlations with 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 and parameters of disease activity.
Meyrier A; Valeyre D; Bouillon R; Paillard F; Battesti JP; Georges R
Q J Med; 1985 Mar; 54(215):269-81. PubMed ID: 3838815
[TBL] [Abstract][Full Text] [Related]
19. Follow-up results of myositis patients treated with H. P. Acthar gel.
Saygin D; Oddis CV; Marder G; Moghadam-Kia S; Nandkumar P; Neiman N; Dzanko S; Koontz D; Aggarwal R
Rheumatology (Oxford); 2020 Oct; 59(10):2976-2981. PubMed ID: 32160301
[TBL] [Abstract][Full Text] [Related]
20. [Hypercalcemia in sarcoidosis--case report, prevalence, pathophysiology and therapeutic options].
Ackermann D
Ther Umsch; 2007 May; 64(5):281-6. PubMed ID: 17685088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
